Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor α Inhibition

20051,238 citationsJournal Articlebronze Open Access

Authors

Abatacept produced significant clinical and functional benefits in patients who had had an inadequate response to anti-TNF-alpha therapy.

Good health and well-being

Published in: New England Journal of Medicine

Volume 353, Issue 11, pp. 1114-1123

Field-Weighted Citation Impact: 51.91